SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem informs about analyst meet

19 May 2022 Evaluate

Pursuant to Regulation 30 and Para (A) of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Meghmani Finechem has informed that the Company is having One-on-one VC with Chrys Capital Advisors on Friday, 20th May, 2022.

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1209.00 39.70 (3.40%)
22-Apr-2026 15:40 View Price Chart
Peers
Company Name CMP
BASF India 3766.25
Tata Chemicals 711.35
SRF 2488.70
Pidilite Inds. 1419.50
Deepak Nitrite 1746.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×